PHARMACOECONOMIC STUDY OF THE USE OF RITUXIMAB FOR SUBCUTANEOUS ADMINISTRATION IN THE TREATMENT OF FOLLICULAR LYMPHOMA

被引：0
|
作者：
Kulikov, A. [1 ]
Rybchenko, Y. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN190
引用
收藏
页码：A463 / A463
页数：1
相关论文
共 50 条
  • [31] Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma
    Buchegger, Franz
    Press, Oliver W.
    EJNMMI RESEARCH, 2011, 1
  • [32] Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma
    Aguiar-Bujanda, David
    Jesus Blanco-Sanchez, Maria
    Hernandez-Sosa, Maria
    Galvan-Ruiz, Saray
    Hernandez-Sarmiento, Samuel
    CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 319 - 330
  • [33] Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab
    Ferrer, A
    López-Guillermo, A
    Montoto, S
    Estrach, T
    Colomo, L
    Montserrat, E
    ANNALS OF HEMATOLOGY, 2001, 80 (08) : 479 - 481
  • [34] Intralesional rituximab for the treatment of localised palatal relapse of follicular lymphoma
    Peinert, Stefan
    Kamel, Sarah
    Seymour, John F.
    Prince, H. Miles
    LEUKEMIA & LYMPHOMA, 2009, 50 (02) : 303 - 305
  • [35] A Two-Stage Phase Ib Study to Investigate the Pharmacokinetics, Safety and Tolerability of Subcutaneous Rituximab In Patients with Follicular Lymphoma as Part of Maintenance Treatment
    Salar, Antonio
    Bouabdallah, Reda
    McIntyre, Christine
    Sayyed, Pakeeza
    Bittner, Beate
    BLOOD, 2010, 116 (21) : 1177 - 1177
  • [36] Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non-interventional study MabSCale
    Duerig, Jan
    Uhlig, Jens
    Gerhardt, Anke
    Ritter, Markus
    Hapke, Gunnar
    Hessling, Joerg
    Staib, Peter
    Wolff, Frieder
    Krumm, Katja
    von Weikersthal, Ludwig Fischer
    CANCER MEDICINE, 2023, 12 (03): : 2739 - 2751
  • [37] SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB ADMINISTRATION IN FIRST-LINE DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA: PREFMAB STUDY OF PATIENT PREFERENCE AND SATISFACTION IN 19 COUNTRIES
    Rummel, M.
    Kim, T. M.
    Jensen, P.
    Pereira, W. V.
    Re, F.
    Mendoza, M.
    Osborne, S.
    Smith, R.
    Grigg, A.
    HAEMATOLOGICA, 2016, 101 : 393 - 393
  • [38] COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA
    Gironella, M.
    Gallardo-Escudero, J.
    Gomez-Barrera, M.
    Jarque, I
    Becares Martinez, F. J.
    Poveda, J. L.
    Martinez-Sesmero, J. M.
    Oyaguez, I
    HAEMATOLOGICA, 2019, 104 : 93 - 93
  • [39] Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma
    Hill, Brian T.
    Nastoupil, Loretta
    Winter, Allison M.
    Becnel, Melody R.
    Cerhan, James R.
    Habermann, Thomas M.
    Link, Brian K.
    Maurer, Matthew J.
    Fakhri, Bita
    Reddy, Prathima
    Smith, Stephen D.
    Mukhija, Dhruvika
    Jagadeesh, Deepa
    Desai, Amrita
    Alderuccio, Juan Pablo
    Lossos, Izidore S.
    Mehra, Pooja
    Portell, Craig A.
    Goldman, Max L.
    Calzada, Oscar
    Cohen, Jonathon B.
    Hussain, Mohammad J.
    Ghosh, Nilanjan
    Caimi, Paolo
    Tiutan, Timothy
    Martin, Peter
    Kodali, Abhigna
    Evens, Andrew M.
    Kahl, Brad S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) : 524 - 535
  • [40] COST-MINIMISATION ANALYSIS OF SUBCUTANEOUS VS INTRAVENOUS RITUXIMAB FOR THE TREATMENT OF FOLLICULAR LYMPHOMA AND DIFFUSE LARGE B-CELL LYMPHOMA IN SINGAPORE
    Choi, M. H.
    Lim, S.
    Wong, A.
    VALUE IN HEALTH, 2018, 21 : S16 - S16
12345